Overall, COVID-19 hospitalizations are decreasing nationwide. However, nearly half of states are seeing an increase, according to data tracked by The New York Times.
Public Health
Two adults over 60 developed Guillain-Barre syndrome after receiving Pfizer's respiratory syncytial virus vaccine candidate in a phase 3 trial. Now the FDA is asking the pharmaceutical giant to conduct a safety study.
A Florida man died after being infected with a rare amoeba while practicing daily sinus rinsing with tap water, the CDC told Fox affiliate WFTX.
In a unanimous vote, a CDC advisory panel voted Feb. 22 in favor of recommending mpox vaccination only for at-risk adults.
Flu activity continues to dwindle nationwide, and although its patterns are hard to predict, experts say there has not been evidence to suggest influenza B will drive a second wave.
The FDA expanded its recall for eye drops potentially contaminated with a highly drug-resistant bacteria that has hospitalized 16 and blinded six patients, CBS News reported Feb. 22.
The CDC is sending epidemiologists and environmental health scientists to the area in Ohio where a train derailed in early February, Politico reported Feb. 21.
Norovirus rates continue to climb after the CDC recently reported 15 percent of test results for the virus are coming back positive nationwide — the highest rate since March, ABC News reported Feb. 10.
A large, seven-year study found 20 minutes of daily exercise reduced hospitalizations from 4 percent to 23 percent for different conditions, U.S. News and World Report reported Feb. 20.
The Pennsylvania Department of Health is suing Spotlight PA after the publication requested information about how patients obtain medical marijuana cards, PBS affiliate WHYY reported Feb. 16.